JG
AMRX icon

Joel Greenblatt’s Amneal Pharmaceuticals AMRX Stock Holding History

Joel Greenblatt’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-22,308
Closed -$277K – 1798
2026
Q1 		$277K Buy
22,308
+2,785
+14% +$37.4K ﹤0.01% 1620
2025
Q4 		$246K Sell
19,523
-6,137
-24% -$70.2K ﹤0.01% 1618
2025
Q3 		$257K Sell
25,660
-34,543
-57% -$310K ﹤0.01% 1546
2025
Q2 		$487K Buy
60,203
+7,534
+14% +$56.8K ﹤0.01% 1329
2025
Q1 		$441K Sell
52,669
-35,214
-40% -$294K ﹤0.01% 1271
2024
Q4 		$696K Buy
87,883
+40,224
+84% +$337K 0.01% 1029
2024
Q3 		$397K Buy
+47,659
New +$373K ﹤0.01% 1159
2024
Q2 		– Sell
-25,322
Closed -$153K – 1414
2024
Q1 		$153K Buy
+25,322
New +$143K ﹤0.01% 1310
2021
Q4 		– Sell
-10,629
Closed -$57K – 1135
2021
Q3 		$57K Sell
10,629
-10,300
-49% -$51.9K ﹤0.01% 1002
2021
Q2 		$107K Buy
+20,929
New +$119K ﹤0.01% 972
2020
Q4 		– Sell
-11,503
Closed -$45K – 989
2020
Q3 		$45K Sell
11,503
-660
-5% -$2.82K ﹤0.01% 1002
2020
Q2 		$58K Sell
12,163
-1,213
-9% -$5K ﹤0.01% 1025
2020
Q1 		$47K Sell
13,376
-1,102
-8% -$4.67K ﹤0.01% 1029
2019
Q4 		$70K Buy
+14,478
New +$50.3K ﹤0.01% 1082
2019
Q3 		– Sell
-30,883
Closed -$221K – 1082
2019
Q2 		$221K Sell
30,883
-18,631
-38% -$190K ﹤0.01% 1044
2019
Q1 		$702K Buy
+49,514
New +$654K 0.01% 759

Other funds holding AMRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Joel Greenblatt's AMRX Position: Q2 2026 in Review

Joel Greenblatt sold out of Amneal Pharmaceuticals (AMRX) in Q2 2026, closing a stake of 22,308 shares — an estimated $277K sold.

Joel Greenblatt first reported a position in AMRX in Q1 2019 and held it in 16 quarters. The position peaked at $702K in Q1 2019. 305 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • Joel Greenblatt reported no remaining Amneal Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Joel Greenblatt sold 22,308 Amneal Pharmaceuticals shares in Q2 2026, an estimated $277K.
  • Joel Greenblatt first reported a position in Amneal Pharmaceuticals in Q1 2019 and held it in 16 quarters.
  • Joel Greenblatt's Amneal Pharmaceuticals position peaked at $702K in Q1 2019.
  • 305 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.